As the year nears its end, surprises continue to make news in chain drug retailing. Mostly, negative surprises. Earlier this month, CVS downsized its headquarters staff by some 600 employees, stopping for a moment the retailer’s uninterrupted string of good news.
The Food Marketing Institute’s recent cancellation of FMI Connect, the trade show that had been scheduled for McCormick Place in Chicago next June, raises some interesting questions about the value and long-term viability of such events.
In chain drug retailing, the most disappointing product category in 2016 has been beauty care. Indeed, the problem with the beauty care category in chain drug stores is, quite simply, the chain drug store’s inability to generate any significant interest in the category.
The United Nations Foundation last month recognized five individuals and organizations whose support has helped the UN address a range of serious issues around the globe.
Our nation’s health care industry is under tremendous pressure to change in order to make quality health care delivery more affordable and accessible. Escalating costs are shifting our health care economy from traditional fee-for-service to value-based payment models.
In the early 1960s, Bob Dylan, who was just awarded the Nobel Prize in Literature, asked his listeners to “… admit that the waters/Around you have grown/And accept it that soon you be drenched to the bone/If your time to you is worth savin’/Then you better start swimmin’ or you’ll sink like a stone/
indeed, three months have passed since the NACDS Total Store Expo gathered the industry together in Boston. Against that background, the NACDS year-end meetings, scheduled for New York City following
There has been a long-standing debate over the size of the vitamins, minerals and supplements (VMS) category. We started our Vitamin Study in 2005 with a simple goal: to get a more accurate measurement of the category size. With our 2016 study, we offered a broader and more robust set of data
and, typically of a business that continues to grow, prosper and change, the tendency is to forget to remember what these icons accomplished. Last month, two executives who were instrumental in building chain drug retailing passed away. They were radically different, yet remarkably
Steve Anderson joined a select group of business leaders last month when he was recognized as trade association CEO of the year.
One of the more surprising aspects of the sad spectacle leading up to the election of a new president and new Congress in November is the lack of serious, sustained debate about health care.
The International Federation of Pharmaceutical Wholesalers held its 2016 General Membership Meeting in London in mid-September. No one can blame you for not immediately recognizing IFPW.
which brings together aspects of the industry that the association previously addressed in three separate shows — hit its stride in terms of fostering interaction between retailers and suppliers, with the Meet the Market
The all-important Christmas selling season is about to begin. Truth is, the season begins during the run-up to Halloween and runs, virtually non-stop, through December 24.
When we at Clavis Insight talk to over-the-counter medicine manufacturers about managing their presence and performance in online stores, there are often still team members who consider the online channel irrelevant for their category.
The explosion of data, analytics, and insights is shifting the ways that health care companies can create value. In a roundtable I recently facilitated on this subject at an industry summit, three themes emerged.
